GlassScriptPhysician profile
Rome C Walter
NPI 1982804365
$6,547.90
in general payments reported to CMS, 2019-2025
40 companies · $1,616 in 2025
The $1,616 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $408 · 2020: $683 · 2021: $680 · 2022: $696 · 2023: $1,044 · 2024: $1,422 · 2025: $1,616.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,081.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,081.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,087.18 | 2020-2025 | Ubrelvy, Vraylar, Qulipta |
| Astrazeneca Pharmaceuticals LP | $751.58 | 2020-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $628.63 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Daiichi Sankyo INC. | $504.54 | 2019-2024 | Injectafer |
| Novo Nordisk INC | $385.39 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $343.10 | 2021-2025 | Arexvy, Shingrix |
| Antares Pharma, INC. | $315.79 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Axsome Therapeutics, INC. | $286.21 | 2023-2025 | Auvelity |
| Allergan, INC. | $241.12 | 2019-2020 | |
| Pfizer INC. | $230.98 | 2019-2025 | |
| Abbott Laboratories | $227.04 | 2021-2025 | Freestyle Libre 3 |
| Amgen INC. | $182.34 | 2020-2025 | Otezla, Repatha, Otezla |
| Exact Sciences Corporation | $140.61 | 2023-2025 | Cologuard Collection Kit |
| Verity Pharmaceuticals INC. | $118.10 | 2024-2025 | Tlando |
| Dexcom, INC. | $112.73 | 2024-2025 | Dexcom G6 Transmitter |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rome Walter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.